[Hemolysis, formation of Heinz bodies and of methemoglobin under therapy with Azulfidine (author's transl)].
D000328:Adult; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003490:Cyanosis / Q000139:chemically induced; D003967:Diarrhea / Q000188:drug therapy; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D006261:Headache / Q000139:chemically induced; D006366:Heinz Bodies / Q000187:drug effects*; D006402:Hematologic Diseases / Q000139:chemically induced; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008551:Melena / Q000188:drug therapy; D008708:Methemoglobinemia / Q000139:chemically induced*; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use; D013610:Tachycardia / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D012460:Sulfasalazine
Hämolyse, Heinz-Körper- und Methämoglobinbildung unter Azulfidine -Therapie.